Foley Partner Antoinette Konski was quoted in an article that appeared in Drug Discovery News on September 2, 2011 titled “Stem Cell Case is Dismissed.” Konski discusses a federal judge’s dismissal of a case seeking to end government funding for human embryonic stem cell research (hESC). She summarizes the decision as a validation of the National Institute of Health’s guidelines regarding stem cell research, adding that it removed a great deal of uncertainty around federal funding of hESC.
Click here to read the complete article.
People
Related News
06 February 2025
In the News
Vanessa Miller Assesses Panama Canal Discourse
Foley & Lardner LLP partner Vanessa Miller commented in SupplyChainBrain article, "The Fight for Control of the Panama Canal," lending important context to the recent headlines over the important waterway.
06 February 2025
In the News
Gregory Husisian Weighs in on Suspension of De Minimis Trade Exemption
Foley & Lardner LLP partner Gregory Husisian offered context on President Trump's recent trade actions on China in The Wall Street Journal article, "Why Trump Is Closing a Trade Exemption for China."
04 February 2025
In the News
Andrew Wronski on Tariff Fluidity – 'Keep on top of the issues'
Foley & Lardner LLP partner Andrew Wronski assessed the evolving shift in U.S. trade policy in the Milwaukee Business Journal article, "Trump tariffs won't disappear — so how should Wisconsin businesses prepare?"